Our results highlighted that the mucosal and blood-based diagnostic performance of FCN1 in IBD was superior to that of S100A8 and S100A9, further supporting the potential clinical value of FCN1 in PIBD diagnosis. This evidence concerns the gene FCN1 and inflammatory bowel disease.